Early recognition of illnesses is essential for improving patient outcomes and reducing the burden of chronic conditions. Traditionally, disease assessment has relied on symptomatic observations and destructive diagnostic methods. However, these techniques often fail to detect diseases in their preclinical stages, when therapy is most effective. Em